Navigation Links
Common Industrial Chemicals May Not Boost Cancer Risk
Date:4/8/2009

Use of PFOA, PFOS as additives is already being phased out, experts note,,,,

WEDNESDAY, April 8 (HealthDay News) -- Typical exposures to chemicals that are found in a wide range of products, and have been linked to cancer in animals, may not boost risks for a range of malignancies in humans, a new report finds.

The two chemicals, perfluorooctanoate and perfluorooctanesulfonate (PFOA, PFOS) have for decades been ubiquitous in food packaging, pesticides, clothing, upholstery, carpets and personal care products. Earlier studies have found these chemicals in the blood of both people exposed to the chemicals at work and in the general public. High concentrations of the chemicals are associated with cancer in animals, but whether they are linked to cancer in humans is unclear.

One recent study, published in January in Human Reproduction, suggested that PFOA/PFOS might also impair women's ability to become pregnant.

However, the new study, published in the April 7 issue of the Journal of the National Cancer Institute, finds that the chemicals may not be associated with an increased risk for prostate, bladder, pancreatic, or liver cancer.

"This is the first study of PFOA/PFOS and cancer risk in a general population, and the results should, therefore, be treated with caution," said lead researcher Ole Raaschou-Nielsen, a senior researcher at the Institute of Cancer Epidemiology at the Danish Cancer Society in Copenhagen. "This is the beginning of the story rather than the end, since several more studies should be conducted before we can make final conclusions," he said.

"We would not recommend any action or changes in behavior based on the results of this single study," he added. "Future studies should confirm or reject the results of our study before practical implications should be considered."

For the study, the researchers collected data on a large group of Danes who were cancer-free when they were enrolled in the study between 1993 and 1997. The researchers identified 713 people who were later diagnosed with prostate cancer, 332 with bladder cancer, 128 with pancreatic cancer, and 67 with liver cancer. They compared these people with 772 people without cancer.

They also divided the participants into four groups based on their blood levels of PFOA and PFOS.

"We find no association between plasma concentrations of PFOA and PFOS and risk for prostate, bladder, pancreatic, or liver cancer in the general Danish population," Raaschou-Nielsen said.

This study did not investigate a possible cancer risk with higher blood levels of PFOA/PFOS, which can occur among people who work with these chemicals or people living in the vicinity of a chemical plant that pollutes the environment with PFOA/PFOS, Raaschou-Nielsen said.

Any danger with these chemicals may soon become moot, since, in 2006, the U.S. Environmental Protection Agency (EPA) had commitments from eight manufacturers of PFOA to voluntarily reduce emissions and product content of PFOA and related chemicals in the United States and overseas by 95 percent by 2010, and to work toward eliminating emissions and product content of these chemicals by 2015. This action was brought on because the chemical was associated with what the EPA called "systemic and developmental toxicity."

In addition, 3M, the only manufacturer of PFOS in the United States, had agreed to phase out its production and use of the chemical nine years ago, according to the EPA's Web site.

Dr. Michael J. Thun, vice president emeritus for Epidemiology and Surveillance Research at the American Cancer Society, believes the findings are interesting but not conclusive.

"The optimal solution is not to be absorbing these chemicals," Thun said. "The process of proving that they are safe is an impossible task. There are so many different conditions. and it's impossible to look at every single condition that they might affect," he said.

"The bottom line for the public is, 'Great, these chemicals don't cause these cancers -- but I'd rather not have it in my body at all,' " Thun said.

More information

For more about environmental cancer risks, visit the U.S. National Cancer Institute.



SOURCES: Ole Raaschou-Nielsen, Ph.D., senior researcher, Institute of Cancer Epidemiology, Danish Cancer Society, Copenhagen, Denmark; Michael J. Thun, M.D., vice president emeritus, Epidemiology and Surveillance Research, American Cancer Society; April 7, 2009, Journal of the National Cancer Institute


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Hair Product Line Addresses Common Scalp Conditions of Teens and Tweens
2. Authentidate Buys Back Shares of its Common Stock
3. Novavax Announces Closing of $11 Million Common Stock Sale to Subsidiary of Cadila Pharmaceuticals
4. Drug commonly used for alcoholism, drug addiction, curbs urges of compulsive stealers
5. New Device Treats Common Heart Rhythm Disorder
6. Using Too Much Salt Is Common in U.S., CDC Says
7. Fish in U.S. Rivers Tainted With Common Medications
8. Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders
9. High Blood Fat Levels Common in Americans
10. Anpath Group, Inc. Announces Intent To Seek Shareholder Approval for a Reverse Split of Its Common Stock
11. Sports Concussions: Common and Preventable
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Common Industrial Chemicals May Not Boost Cancer Risk
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the Mountains to the Mission ... lost souls in the Philippines. “The Journey: From the Mountains to the Mission Field” ... the Bible. She has taught all ages and currently teaches a class of ladies ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... , ... Asante, a nationally recognized health system in southern ... home health joint venture through an agreement, effective October 1, 2017, to create ... health company with Asante, delivering clinically integrated care, for the past eight years. ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... BALTIMORE (PRWEB) , ... October 12, 2017 , ... ... average of $3,296 in property taxes a year. In some states—like New York, ... higher. , By contrast, many overseas retirement havens have extremely low property-tax rates, ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology: